Clinical Trials Logo

Recurrent Genital Herpes clinical trials

View clinical trials related to Recurrent Genital Herpes.

Filter by:
  • None
  • Page 1

NCT ID: NCT00171990 Completed - Clinical trials for Recurrent Genital Herpes

Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes

Start date: January 2003
Phase: Phase 3
Study type: Interventional

This is a phase III, multicenter, randomized, double-blind, parallel-group study to compare the efficacy and safety of a two-day treatment with famciclovir (500 mg loading dose followed by 250 mg 12-hourly) to standard five-day treatment with famciclovir (125 mg 12-hourly) in patients with active recurrent genital herpes. This study is not recruiting patients in the United States.